Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 16, 2024Open Access

New approaches to combat Antimicrobial Resistance (AMR)?

View Full Paper
Ask AI
Bookmark
Share

Authors

LDLouis DillacWCW. J. ChristieDDDanielle van Dalen

Discussion

Loading...

Member takes

Overview

This article examines EU actions on antimicrobial resistance, highlighting the need for public-private partnerships and education.

Key Points

  • Antimicrobial resistance is a global health challenge exacerbated by improper antibiotic usage in humans and animals.
  • The European Commission's strategy focuses on new antibiotic development but also emphasizes education and equitable access.
  • Innovations in drug development may inadvertently contribute to resistance, requiring a balanced approach to antibiotic usage.
  • Legal bans and regulatory measures in agriculture are essential to reduce antibiotic overuse, drawing lessons from China’s practices.

Cite This Study

Dillac et al. (2025) studied this question.

synapsesocial.com/papers/689a02afe6551bb0af8cbe89https://doi.org/10.31219/osf.io/mhbuj_v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global Strategies for Combating Antimicrobial Resistance through the One Health Approach: A Mini Review2025 · 3 citations
  2. 2Unmasking the Silent Pandemic of Antimicrobial Resistance (AMR): A Comprehensive Review2025 · 4 citations
  3. 3Exploring the Societal Impact of Antimicrobial Resistance2025
  4. 4Antimicrobial Resistance As A Global Health Threat: A Review Of Antibiotic Use Patterns, Policies, And Cross-Country Impacts2025
  5. 5Current Trends and Future Directions in Antimicrobial Resistance and Novel Drug Strategies2025